首页 > 最新文献

Materia socio-medica最新文献

英文 中文
Preliminary Results of the Efficacy and Safety of Cryoablation for Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation: a Study From Vietnam. 冻融治疗阵发性心房颤动肺静脉隔离的有效性和安全性的初步结果:来自越南的研究。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.54-57
Nguyen Duy Linh, Phan Dinh Phong, Tran Song Giang, Pham Tran Linh, Bui The Dung, Do Doan Loi, Pham Minh Tuan

Background: Atrial fibrillation is the most common type of arrhythmia. The symptoms of atrial fibrillation not only significantly impacted quality of life but also associated with thrombotic events and heart failure, thereby increased risk of mortality. According to current guidelines, the initial treatment strategy for patients with atrial fibrillation is antiarrhythmic medication.

Objective: This study aimed to evaluate the safety, efficacy, and procedural adaptations required for cryoablation in Vietnamese patients with paroxysmal atrial fibrillation (AF).

Methods: Fifteen patients with paroxysmal AF underwent cryoablation using a standardized protocol. Patient characteristics, procedural parameters, and outcomes were recorded. Safety was assessed by monitoring acute complications, and procedural success was defined as complete pulmonary vein isolation (PVI) confirmed by bidirectional block.

Results: Complete PVI was achieved in 100% of patients, with an average procedural duration of 125 ± 32 minutes and fluoroscopy time of 14 ± 8 minutes. No acute complications related to cryoablation.

Conclusion: Cryoablation demonstrated safety and efficacy in achieving PVI for paroxysmal AF in a resource-limited setting. Larger studies with extended follow-up are required to further validate these outcomes and explore the long-term efficacy and sustainability of cryoablation techniques.

背景:心房颤动是最常见的心律失常类型。房颤的症状不仅显著影响生活质量,而且与血栓事件和心力衰竭相关,从而增加死亡风险。根据目前的指南,房颤患者的初始治疗策略是抗心律失常药物。目的:本研究旨在评估越南阵发性心房颤动(AF)患者冷冻消融的安全性、有效性和程序适应性。方法:15例阵发性房颤患者采用标准方案进行冷冻消融治疗。记录患者特征、手术参数和结果。通过监测急性并发症来评估安全性,手术成功定义为双向阻断确认完全肺静脉隔离(PVI)。结果:100%的患者实现完全PVI,平均手术时间125±32分钟,透视时间14±8分钟。无与冷冻消融相关的急性并发症。结论:在资源有限的情况下,冷冻消融在实现阵发性房颤PVI方面具有安全性和有效性。需要更大规模的随访研究来进一步验证这些结果,并探索冷冻消融技术的长期疗效和可持续性。
{"title":"Preliminary Results of the Efficacy and Safety of Cryoablation for Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation: a Study From Vietnam.","authors":"Nguyen Duy Linh, Phan Dinh Phong, Tran Song Giang, Pham Tran Linh, Bui The Dung, Do Doan Loi, Pham Minh Tuan","doi":"10.5455/msm.2025.37.54-57","DOIUrl":"10.5455/msm.2025.37.54-57","url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation is the most common type of arrhythmia. The symptoms of atrial fibrillation not only significantly impacted quality of life but also associated with thrombotic events and heart failure, thereby increased risk of mortality. According to current guidelines, the initial treatment strategy for patients with atrial fibrillation is antiarrhythmic medication.</p><p><strong>Objective: </strong>This study aimed to evaluate the safety, efficacy, and procedural adaptations required for cryoablation in Vietnamese patients with paroxysmal atrial fibrillation (AF).</p><p><strong>Methods: </strong>Fifteen patients with paroxysmal AF underwent cryoablation using a standardized protocol. Patient characteristics, procedural parameters, and outcomes were recorded. Safety was assessed by monitoring acute complications, and procedural success was defined as complete pulmonary vein isolation (PVI) confirmed by bidirectional block.</p><p><strong>Results: </strong>Complete PVI was achieved in 100% of patients, with an average procedural duration of 125 ± 32 minutes and fluoroscopy time of 14 ± 8 minutes. No acute complications related to cryoablation.</p><p><strong>Conclusion: </strong>Cryoablation demonstrated safety and efficacy in achieving PVI for paroxysmal AF in a resource-limited setting. Larger studies with extended follow-up are required to further validate these outcomes and explore the long-term efficacy and sustainability of cryoablation techniques.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 1","pages":"54-57"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Non-pharmacological Herbs in Treating Cough and Respiratory Symptoms in Saudi Arabia: a Multi-center Study. 在沙特阿拉伯使用非药物草药治疗咳嗽和呼吸道症状:一项多中心研究
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.18-23
Abdullah A Yousef, Abdullah Al-Shamrani, Alzahra Y Alradhi, Fatimah M Bukhamsen, Aqilah T Alqassab, Sumayyah A Kobeisy, Saleh AlHarbi, Halima AlalKami, Ahmed M Alrashdan

Background: Herbal medicinal products, a subgroup of complementary and alternative therapy (CAM), are widely used for pediatric respiratory symptoms in Saudi Arabia. However, regional variations and safety concerns remain understudied.

Objective: This study examines the prevalence and patterns of herbal remedy use for cough and respiratory illness among Saudi children.

Methods: A multi-center cross-sectional questionnaire-based study was conducted across five Saudi regions (N=475). Data were collected via a validated questionnaire (Cronbach's α = 0.85) and analyzed using SPSS v25.

Results: The mean age was 3.97 ± 3.60 years. Herbal remedy use was highest in the Western province (37.8%, p <0.001). Sesame oil (19.8%) and olive oil (18.2%) were most common. Family/friends provided 82.8% of advice. Self-rated improvement was "excellent/good" in 59.9%, with 96.6% reporting no adverse effects. Fathers with postgraduate degrees used fewer herbal remedies (p=0.003).

Conclusion: Herbal remedy use is prevalent, emphasizing the need for healthcare providers to document usage and educate families. Further research is required to evaluate efficacy and safety.

背景:作为补充和替代疗法(CAM)的一个亚组,草药产品在沙特阿拉伯广泛用于儿童呼吸道症状。然而,地区差异和安全问题仍未得到充分研究。目的:本研究考察了沙特儿童咳嗽和呼吸系统疾病中草药使用的患病率和模式。方法:在沙特五个地区(N=475)进行了一项多中心横断面问卷研究。采用有效问卷(Cronbach’s α = 0.85)收集数据,并使用SPSS v25进行分析。结果:患者平均年龄3.97±3.60岁。结论:中草药的使用是普遍的,强调卫生保健提供者需要记录使用情况并教育家庭。需要进一步的研究来评估其有效性和安全性。
{"title":"The Use of Non-pharmacological Herbs in Treating Cough and Respiratory Symptoms in Saudi Arabia: a Multi-center Study.","authors":"Abdullah A Yousef, Abdullah Al-Shamrani, Alzahra Y Alradhi, Fatimah M Bukhamsen, Aqilah T Alqassab, Sumayyah A Kobeisy, Saleh AlHarbi, Halima AlalKami, Ahmed M Alrashdan","doi":"10.5455/msm.2025.37.18-23","DOIUrl":"10.5455/msm.2025.37.18-23","url":null,"abstract":"<p><strong>Background: </strong>Herbal medicinal products, a subgroup of complementary and alternative therapy (CAM), are widely used for pediatric respiratory symptoms in Saudi Arabia. However, regional variations and safety concerns remain understudied.</p><p><strong>Objective: </strong>This study examines the prevalence and patterns of herbal remedy use for cough and respiratory illness among Saudi children.</p><p><strong>Methods: </strong>A multi-center cross-sectional questionnaire-based study was conducted across five Saudi regions (N=475). Data were collected via a validated questionnaire (Cronbach's α = 0.85) and analyzed using SPSS v25.</p><p><strong>Results: </strong>The mean age was 3.97 ± 3.60 years. Herbal remedy use was highest in the Western province (37.8%, p <0.001). Sesame oil (19.8%) and olive oil (18.2%) were most common. Family/friends provided 82.8% of advice. Self-rated improvement was \"excellent/good\" in 59.9%, with 96.6% reporting no adverse effects. Fathers with postgraduate degrees used fewer herbal remedies (p=0.003).</p><p><strong>Conclusion: </strong>Herbal remedy use is prevalent, emphasizing the need for healthcare providers to document usage and educate families. Further research is required to evaluate efficacy and safety.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 1","pages":"18-23"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Behavioral Medicine in Preventive Healthcare. 预防保健中的行为医学。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.213-219
Ibrahim Abdul Jaleel Yamani, Izzeldeen Abdullah Alnaimi, Ahed J Alkhatib

Background: The biomedical sciences associated with the behavior of humans dissipate diseases and its development is called behavioral medicine. Drawing together insights from medicine, neuroscience, psychoneuroimmunology, psychology, sociology epidemiology, anthropology, and health education, it looks at health in the biological, psychological social environmental and spiritual.

Objective: The objectives of this study were: a) to specify the scope and domains of modern behavioral medicine, b) to clarify prevention, diagnosis, treatment, and outcomes, c) to specify the patient-physician relationship and technology use, and d) to describe how behavioral medicine links delivery, utilization, education, and reform of health and social systems.

Methods: The methodology involves looking at differing complex comprehensive models as well as the models that control functioning in illness and disease.

Results: Today's behavioral medicine has multiple applications (e.g. clinical care, prevention, health promotion, systems innovation)." It promotes a patient-physician relationship that is socially adept and facilitated by technology. It also addresses health problems of the individual and social problems at the community level. Furthermore, it integrates life and social sciences in order to influence etiology, diagnosis, treatment and health outcome through the cognitive, emotional, psychosocial and environmental pathways. The discipline seeks to unite the health system family, focusing on wellness rather than illness.

Conclusion: Behavioral medicine acts as an integrative platform for disciplines and health systems that further prevention, diagnosis, treatment, and population health. This allows for comprehensive, scalable approaches to enhance health outcomes and inform health system reform by focusing on the patient-physician relationship, utilizing appropriate technology and acting at the level of individuals and communities.

背景:与人类行为有关的生物医学科学是一门治疗疾病的学科,它的发展被称为行为医学。它汇集了医学、神经科学、心理神经免疫学、心理学、社会学、流行病学、人类学和健康教育的见解,从生物、心理、社会、环境和精神的角度来看待健康。目的:本研究的目的是:a)明确现代行为医学的范围和领域,b)明确预防、诊断、治疗和结果,c)明确医患关系和技术使用,d)描述行为医学如何将卫生和社会系统的交付、利用、教育和改革联系起来。方法:该方法包括观察不同的复杂综合模型以及控制疾病和疾病功能的模型。结果:今天的行为医学有多种应用(如临床护理、预防、健康促进、系统创新)。它促进了一种医患关系,这种关系在社会上是熟练的,并由技术促进。它还处理个人健康问题和社区一级的社会问题。此外,它整合了生命科学和社会科学,以便通过认知、情感、社会心理和环境途径影响病因、诊断、治疗和健康结果。该学科寻求将卫生系统大家庭团结起来,关注健康而不是疾病。结论:行为医学作为学科和卫生系统的综合平台,进一步促进预防、诊断、治疗和人群健康。这允许采用全面、可扩展的方法,通过注重医患关系、利用适当技术和在个人和社区层面采取行动,提高卫生结果并为卫生系统改革提供信息。
{"title":"Behavioral Medicine in Preventive Healthcare.","authors":"Ibrahim Abdul Jaleel Yamani, Izzeldeen Abdullah Alnaimi, Ahed J Alkhatib","doi":"10.5455/msm.2025.37.213-219","DOIUrl":"10.5455/msm.2025.37.213-219","url":null,"abstract":"<p><strong>Background: </strong>The biomedical sciences associated with the behavior of humans dissipate diseases and its development is called behavioral medicine. Drawing together insights from medicine, neuroscience, psychoneuroimmunology, psychology, sociology epidemiology, anthropology, and health education, it looks at health in the biological, psychological social environmental and spiritual.</p><p><strong>Objective: </strong>The objectives of this study were: a) to specify the scope and domains of modern behavioral medicine, b) to clarify prevention, diagnosis, treatment, and outcomes, c) to specify the patient-physician relationship and technology use, and d) to describe how behavioral medicine links delivery, utilization, education, and reform of health and social systems.</p><p><strong>Methods: </strong>The methodology involves looking at differing complex comprehensive models as well as the models that control functioning in illness and disease.</p><p><strong>Results: </strong>Today's behavioral medicine has multiple applications (e.g. clinical care, prevention, health promotion, systems innovation).\" It promotes a patient-physician relationship that is socially adept and facilitated by technology. It also addresses health problems of the individual and social problems at the community level. Furthermore, it integrates life and social sciences in order to influence etiology, diagnosis, treatment and health outcome through the cognitive, emotional, psychosocial and environmental pathways. The discipline seeks to unite the health system family, focusing on wellness rather than illness.</p><p><strong>Conclusion: </strong>Behavioral medicine acts as an integrative platform for disciplines and health systems that further prevention, diagnosis, treatment, and population health. This allows for comprehensive, scalable approaches to enhance health outcomes and inform health system reform by focusing on the patient-physician relationship, utilizing appropriate technology and acting at the level of individuals and communities.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 3","pages":"213-219"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arterial Hypertension and its Impact on the Prescription of Combined Hormonal Contraception. 高血压及其对联合激素避孕处方的影响。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.258-260
Mateja Legan, Lucija Vrabic Dezman, Naneta Legan Kokol, Marko Mlinaric

Background: Combined hormonal contraception (CHC) is a widely accepted contraceptive method for women of reproductive age. It is considered a safe and user-friendly option for women without risk factors for cardiovascular diseases; however, it is contraindicated in women with established cardiovascular disease or overt risk factors. CHC increases the incidence of cardiovascular events through higher risk for thromboembolic events and potential increases of blood pressure.

Objective: The aim of this article was to explain when and how arterial hypertension should be addressed as absolute and relative contraindication for CHC use as well as a possible consequence of CHC therapy.

Methods: This is descriptive method which should be crucial to identify women who are not suitable candidates for CHC by thoroughly assessing their medical history, including current and previous conditions, evaluating potential risk factors, calculating body mass index (BMI), and regularly monitoring blood pressure and weight.

Results and discussion: Several explanations have been proposed to explain blood pressure elevations. The estrogenic component in CHC stimulates renin-angiotensin-Aldosterone system (RAAS) through increased hepatic production of angiotensinogen. The regulation of anti-diuretic hormone (ADH) through osmoreceptors may also be altered. Before prescribing CHC, gynecologists should conduct a thorough cardiovascular risk assessment. This should include a targeted questionnaire addressing cardiovascular disease history and risk factors, such as smoking and elevated lipid levels. Additionally, BMI calculation and blood pressure measurement should be performed. It is advisable to assess thyroid function by measuring THS levels at the initiation of CHC and every five years thereafter, as thyroid dysfunction is associated with increased cardiovascular risk, particularly arterial hypertension Laboratory testing should include lipid profiles, glucose levels and thyroid function assessment performed prior to initiating CHC and at regular intervals during its use. This article focuses on arterial hypertension addressing its role as both an absolute and relative contraindication for CHC use as well as a possible consequence of CHC therapy.

Conclusion: Women with well-controlled arterial hypertension may, in certain circumstances, safely use CHC. The combination of estetrol and drospirenone holds promise as an ideal choice for women with arterial hypertension seeking CHC.

背景:激素联合避孕(CHC)是育龄妇女广泛接受的避孕方法。对于没有心血管疾病风险因素的妇女来说,它被认为是一种安全和用户友好的选择;然而,对于有心血管疾病或明显危险因素的妇女是禁忌的。CHC通过增加血栓栓塞事件的风险和潜在的血压升高而增加心血管事件的发生率。目的:本文的目的是解释何时以及如何将动脉高血压作为CHC使用的绝对和相对禁忌症,以及CHC治疗的可能后果。方法:这是一种描述性方法,通过全面评估其病史,包括当前和以前的情况,评估潜在的危险因素,计算体重指数(BMI),并定期监测血压和体重,确定不适合CHC的女性候选人,这一点至关重要。结果和讨论:对于血压升高的原因,人们提出了几种解释。CHC中的雌激素成分通过增加肝脏血管紧张素原的产生来刺激肾素-血管紧张素-醛固酮系统(RAAS)。通过渗透受体调节抗利尿激素(ADH)也可能发生改变。在开具CHC处方前,妇科医生应进行全面的心血管风险评估。这应包括针对心血管病史和危险因素(如吸烟和血脂水平升高)的有针对性的问卷调查。此外,还应进行BMI计算和血压测量。由于甲状腺功能障碍与心血管风险增加有关,尤其是动脉高血压,因此建议在CHC开始时和之后每5年通过测量甲状腺功能来评估甲状腺功能,实验室检测应包括脂质谱、血糖水平和甲状腺功能评估,这些评估应在CHC开始前进行,并在使用期间定期进行。这篇文章的重点是动脉高血压,阐述其作为CHC使用的绝对和相对禁忌症的作用,以及CHC治疗的可能后果。结论:高血压控制良好的女性在某些情况下可以安全使用CHC。甾醇和屈螺酮联合应用有望成为寻求冠心病的动脉高血压妇女的理想选择。
{"title":"Arterial Hypertension and its Impact on the Prescription of Combined Hormonal Contraception.","authors":"Mateja Legan, Lucija Vrabic Dezman, Naneta Legan Kokol, Marko Mlinaric","doi":"10.5455/msm.2025.37.258-260","DOIUrl":"10.5455/msm.2025.37.258-260","url":null,"abstract":"<p><strong>Background: </strong>Combined hormonal contraception (CHC) is a widely accepted contraceptive method for women of reproductive age. It is considered a safe and user-friendly option for women without risk factors for cardiovascular diseases; however, it is contraindicated in women with established cardiovascular disease or overt risk factors. CHC increases the incidence of cardiovascular events through higher risk for thromboembolic events and potential increases of blood pressure.</p><p><strong>Objective: </strong>The aim of this article was to explain when and how arterial hypertension should be addressed as absolute and relative contraindication for CHC use as well as a possible consequence of CHC therapy.</p><p><strong>Methods: </strong>This is descriptive method which should be crucial to identify women who are not suitable candidates for CHC by thoroughly assessing their medical history, including current and previous conditions, evaluating potential risk factors, calculating body mass index (BMI), and regularly monitoring blood pressure and weight.</p><p><strong>Results and discussion: </strong>Several explanations have been proposed to explain blood pressure elevations. The estrogenic component in CHC stimulates renin-angiotensin-Aldosterone system (RAAS) through increased hepatic production of angiotensinogen. The regulation of anti-diuretic hormone (ADH) through osmoreceptors may also be altered. Before prescribing CHC, gynecologists should conduct a thorough cardiovascular risk assessment. This should include a targeted questionnaire addressing cardiovascular disease history and risk factors, such as smoking and elevated lipid levels. Additionally, BMI calculation and blood pressure measurement should be performed. It is advisable to assess thyroid function by measuring THS levels at the initiation of CHC and every five years thereafter, as thyroid dysfunction is associated with increased cardiovascular risk, particularly arterial hypertension Laboratory testing should include lipid profiles, glucose levels and thyroid function assessment performed prior to initiating CHC and at regular intervals during its use. This article focuses on arterial hypertension addressing its role as both an absolute and relative contraindication for CHC use as well as a possible consequence of CHC therapy.</p><p><strong>Conclusion: </strong>Women with well-controlled arterial hypertension may, in certain circumstances, safely use CHC. The combination of estetrol and drospirenone holds promise as an ideal choice for women with arterial hypertension seeking CHC.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 3","pages":"258-260"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146109401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attitudes of Physicians and Nurses Toward Interprofessional Collaboration: a Systematic Literature Review. 医师和护士对跨专业合作的态度:系统的文献回顾。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.64-73
Polyxeni Lazarou Gregoriou, Andreas Charalambous, Elena Rousou, Evridiki Papastavrou, Anastasios Merkouris

Background: Interprofessional collaboration involves coordinated efforts by professionals from various disciplines, such as physicians and nurses, aimed at improving patient care outcomes. This teamwork enhances cooperation among healthcare professionals with diverse expertise, contributing significantly to patient safety, satisfaction, expedited recovery, cost-effectiveness, and reduced mortality rates.

Objective: This paper explores the available evidence regarding the attitudes of physicians and nurses towards interprofessional collaboration and identifies factors that influence their willingness to engage in collaborative practice.

Methods: A systematic review was conducted spanning from 2016 to 2023, adhering to predefined criteria and the PRISMA guidelines and checklist. Searches were performed in PubMed, Scopus, CINAHL Plus, Cochrane, and Google Scholar. The inclusion criteria comprised studies (regardless of design) addressing interprofessional collaboration, published within the last ten years, and involving both physicians and nurses. Only articles with full text access and written in English or Greek were included.

Results: The review identified 13 relevant studies. The analysis revealed that nurses generally exhibit more favourable attitudes towards interprofessional collaboration compared to physicians. Moreover, thematic analysis highlighted key factors influencing the attitudes of both nurses and physicians, including education level, age and years of experience.

Conclusion: This review highlights critical aspects and gaps in current literature, emphasizing the need for future research to further explore these areas. Findings also underscore the importance of incorporate these insights into hospital policies to effectively enhance interprofessional collaboration.

背景:跨专业合作包括来自不同学科的专业人员的协调努力,如医生和护士,旨在改善患者的护理结果。这种团队合作增强了具有不同专业知识的医疗保健专业人员之间的合作,大大提高了患者的安全性、满意度、加速康复、成本效益和降低死亡率。目的:探讨医生和护士对跨专业合作态度的现有证据,并确定影响他们参与合作实践意愿的因素。方法:根据预先确定的标准和PRISMA指南和检查表,对2016年至2023年进行系统评价。在PubMed, Scopus, CINAHL Plus, Cochrane和b谷歌Scholar中进行了搜索。纳入标准包括在过去十年内发表的涉及医生和护士的跨专业合作的研究(无论设计如何)。只有文章的全文访问和写在英语或希腊语被包括在内。结果:本综述确定了13项相关研究。分析显示,与医生相比,护士普遍对跨专业合作表现出更有利的态度。此外,专题分析强调了影响护士和医生态度的关键因素,包括教育水平、年龄和经验年数。结论:本综述突出了当前文献中的关键方面和空白,强调了未来研究进一步探索这些领域的必要性。研究结果还强调了将这些见解纳入医院政策以有效加强专业间合作的重要性。
{"title":"Attitudes of Physicians and Nurses Toward Interprofessional Collaboration: a Systematic Literature Review.","authors":"Polyxeni Lazarou Gregoriou, Andreas Charalambous, Elena Rousou, Evridiki Papastavrou, Anastasios Merkouris","doi":"10.5455/msm.2025.37.64-73","DOIUrl":"10.5455/msm.2025.37.64-73","url":null,"abstract":"<p><strong>Background: </strong>Interprofessional collaboration involves coordinated efforts by professionals from various disciplines, such as physicians and nurses, aimed at improving patient care outcomes. This teamwork enhances cooperation among healthcare professionals with diverse expertise, contributing significantly to patient safety, satisfaction, expedited recovery, cost-effectiveness, and reduced mortality rates.</p><p><strong>Objective: </strong>This paper explores the available evidence regarding the attitudes of physicians and nurses towards interprofessional collaboration and identifies factors that influence their willingness to engage in collaborative practice.</p><p><strong>Methods: </strong>A systematic review was conducted spanning from 2016 to 2023, adhering to predefined criteria and the PRISMA guidelines and checklist. Searches were performed in PubMed, Scopus, CINAHL Plus, Cochrane, and Google Scholar. The inclusion criteria comprised studies (regardless of design) addressing interprofessional collaboration, published within the last ten years, and involving both physicians and nurses. Only articles with full text access and written in English or Greek were included.</p><p><strong>Results: </strong>The review identified 13 relevant studies. The analysis revealed that nurses generally exhibit more favourable attitudes towards interprofessional collaboration compared to physicians. Moreover, thematic analysis highlighted key factors influencing the attitudes of both nurses and physicians, including education level, age and years of experience.</p><p><strong>Conclusion: </strong>This review highlights critical aspects and gaps in current literature, emphasizing the need for future research to further explore these areas. Findings also underscore the importance of incorporate these insights into hospital policies to effectively enhance interprofessional collaboration.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 1","pages":"64-73"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discriminatory Performance of APACHE II Score and the Prediction of Mortality within the ICU in Patients with Sepsis Admitted to the ICU. APACHE II评分的歧视性表现及对ICU脓毒症患者死亡率的预测
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.153-158
Ahmad Habeeb Dala Ali, Sabariah Noor Harun, Noordin Othman, Baharudin Ibrahim, Omer Elhag Abdulbagi, Ibrahim Abdullah, Indang Ariati Ariffin

Background: Severity of illness assessment tools are utilized to triage critically-ill patients and provide a valuable inputs to the healthcare provider to decide the type and intensity of treatment or interventions.

Objective: The aim of this study was to evaluate the discriminatory capabilities of Acute Physiology And Chronic Health Evaluation II (APACHE II) score in the prediction of Intensive care units (ICUs) mortality among patients with sepsis admitted to the ICU.

Methods: Records of patients with sepsis admitted to ICUs were retrospectively reviewed. Discriminatory performance of APACHE II score was assessed by using the receiver operating characteristic's (ROC's) area under the curve (AUC).

Results: The mean±SD of APACHE II score was 27.1±8.4. APACHE II score demonstrated a very good discriminatory performance with an accuracy rate of 75% and an AUC-ROC 0.80 (95%CI: 0.74 - 0.85) at an optimal cutoff of 26. APACHE II score was found to be correlated with ICU mortality with a correlation coefficient of (0.52). ICU mortality was significantly higher in patients with APACHE II score ≥26.

Conclusion: This study revealed that the discriminatory performance of APACHE II score in predicting ICU mortality in patient with sepsis was very good. These findings can have potential clinical implications in the identification and management of patients with sepsis admitted to the ICU.

背景:疾病严重程度评估工具用于对危重患者进行分类,并为医疗保健提供者提供有价值的输入,以决定治疗或干预的类型和强度。目的:本研究的目的是评估急性生理和慢性健康评估II (APACHE II)评分在预测ICU脓毒症患者重症监护病房(ICU)死亡率方面的区别能力。方法:回顾性分析icu收治的脓毒症患者的记录。采用受试者工作特征(ROC)曲线下面积(AUC)评价APACHE II评分的歧视性表现。结果:APACHEⅱ评分的平均值±SD为27.1±8.4。APACHE II评分显示出非常好的区分性能,准确率为75%,AUC-ROC为0.80 (95%CI: 0.74 - 0.85),最佳截止值为26。APACHEⅱ评分与ICU死亡率相关,相关系数为(0.52)。APACHE II评分≥26的患者ICU死亡率明显增高。结论:本研究显示APACHEⅱ评分在预测脓毒症ICU患者死亡率方面具有很好的歧视性。这些发现可能对ICU脓毒症患者的识别和管理具有潜在的临床意义。
{"title":"Discriminatory Performance of APACHE II Score and the Prediction of Mortality within the ICU in Patients with Sepsis Admitted to the ICU.","authors":"Ahmad Habeeb Dala Ali, Sabariah Noor Harun, Noordin Othman, Baharudin Ibrahim, Omer Elhag Abdulbagi, Ibrahim Abdullah, Indang Ariati Ariffin","doi":"10.5455/msm.2025.37.153-158","DOIUrl":"10.5455/msm.2025.37.153-158","url":null,"abstract":"<p><strong>Background: </strong>Severity of illness assessment tools are utilized to triage critically-ill patients and provide a valuable inputs to the healthcare provider to decide the type and intensity of treatment or interventions.</p><p><strong>Objective: </strong>The aim of this study was to evaluate the discriminatory capabilities of Acute Physiology And Chronic Health Evaluation II (APACHE II) score in the prediction of Intensive care units (ICUs) mortality among patients with sepsis admitted to the ICU.</p><p><strong>Methods: </strong>Records of patients with sepsis admitted to ICUs were retrospectively reviewed. Discriminatory performance of APACHE II score was assessed by using the receiver operating characteristic's (ROC's) area under the curve (AUC).</p><p><strong>Results: </strong>The mean±SD of APACHE II score was 27.1±8.4. APACHE II score demonstrated a very good discriminatory performance with an accuracy rate of 75% and an AUC-ROC 0.80 (95%CI: 0.74 - 0.85) at an optimal cutoff of 26. APACHE II score was found to be correlated with ICU mortality with a correlation coefficient of (0.52). ICU mortality was significantly higher in patients with APACHE II score ≥26.</p><p><strong>Conclusion: </strong>This study revealed that the discriminatory performance of APACHE II score in predicting ICU mortality in patient with sepsis was very good. These findings can have potential clinical implications in the identification and management of patients with sepsis admitted to the ICU.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 2","pages":"153-158"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144556310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rusty Pipe Syndrome: a Rare Syndrome During Breast Feeding-Our Experience. 锈管综合征:母乳喂养中一种罕见的综合征——我们的经验。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.149-152
Georgios Iatrakis, Stefanos Zervoudis, Panagiotis Eskitzis, Vasiliki Michou, Anisa Markja, Panagiotis Peitsidis, Aristidis Tzeferakos, Panagiotis Tsikouras

Background: The presence of blood in breast milk gives it a rusty or brownish color, which is referred to as "Rusty Pipe Syndrome (RPS)".

Objective: This study presents case reports to raise awareness about RPS and examine differences from existing literature.

Methods: Data from six cases with confirmed RPS were collected from Rea Maternity Hospital in Athens, Greece and Alexandroupolis General University Hospital in Alexandroupolis, Greece, from March 2020 until July 2024.

Results: Six women aged 25 to 36, experienced RPS during breastfeeding. The majority of them had no previous birth history (83%), were primigravida (83%) and had bilateral presence of blood in the milk (67%), with symptoms appeared on the second postpartum day (50%).

Conclusion: Based on extensive studies and literature reviews, RPS is generally considered a benign condition, typically presenting bilaterally. However, unilateral cases, such as those observed in our study, are rare.

背景:母乳中有血会使其呈锈色或褐色,这被称为“锈管综合征”。目的:本研究通过病例报告提高对RPS的认识,并分析与现有文献的差异。方法:收集2020年3月至2024年7月在希腊雅典雷亚妇产医院和希腊亚历山德鲁波利斯综合大学医院确诊的6例RPS病例的数据。结果:6名25 ~ 36岁的女性在母乳喂养期间经历了RPS。其中大多数没有分娩史(83%),初产妇(83%),双侧乳中有血(67%),产后第二天出现症状(50%)。结论:基于广泛的研究和文献综述,RPS通常被认为是一种良性疾病,通常表现为双侧。然而,单侧病例,如在我们的研究中观察到的,是罕见的。
{"title":"Rusty Pipe Syndrome: a Rare Syndrome During Breast Feeding-Our Experience.","authors":"Georgios Iatrakis, Stefanos Zervoudis, Panagiotis Eskitzis, Vasiliki Michou, Anisa Markja, Panagiotis Peitsidis, Aristidis Tzeferakos, Panagiotis Tsikouras","doi":"10.5455/msm.2025.37.149-152","DOIUrl":"10.5455/msm.2025.37.149-152","url":null,"abstract":"<p><strong>Background: </strong>The presence of blood in breast milk gives it a rusty or brownish color, which is referred to as \"Rusty Pipe Syndrome (RPS)\".</p><p><strong>Objective: </strong>This study presents case reports to raise awareness about RPS and examine differences from existing literature.</p><p><strong>Methods: </strong>Data from six cases with confirmed RPS were collected from Rea Maternity Hospital in Athens, Greece and Alexandroupolis General University Hospital in Alexandroupolis, Greece, from March 2020 until July 2024.</p><p><strong>Results: </strong>Six women aged 25 to 36, experienced RPS during breastfeeding. The majority of them had no previous birth history (83%), were primigravida (83%) and had bilateral presence of blood in the milk (67%), with symptoms appeared on the second postpartum day (50%).</p><p><strong>Conclusion: </strong>Based on extensive studies and literature reviews, RPS is generally considered a benign condition, typically presenting bilaterally. However, unilateral cases, such as those observed in our study, are rare.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 2","pages":"149-152"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212226/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144556318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver Injury During New Epidemic Occurrence of COVID-19. 新冠肺炎疫情发生过程中的肝损伤
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.261-266
Nizama Salihefendic, Muharem Zildzic, Izet Masic

Background: SARS-CoV-2, though primarily a respiratory pathogen, exhibits multi-organ tropism, with the liver among the commonly affected organs. Elevations in liver enzymes are frequent in hospitalized COVID-19 patients, yet acute and pronounced hepatocellular injury in young, clinically stable individuals is uncommon. The underlying mechanisms may include direct viral cytopathic effects mediated by ACE2 receptors, immune-mediated injury, systemic inflammation, and metabolic stress. Notably, hepatic involvement can develop independently of respiratory compromise.

Objective: The aim of this case report was to describe three adult patients with serologically confirmed SARS-CoV-2 infection and mild respiratory symptoms who presented with acute liver injury in the absence of other identifiable causes.

Case report: During a confirmed COVID-19 wave in Bosnia and Herzegovina, a targeted outpatient study was performed in a family medicine setting. Routine liver testing was conducted for all suspected COVID-19 cases. Laboratory evaluation included liver enzymes, hepatitis serology, autoimmune markers, and inflammatory parameters, with imaging (ultrasound or MRI) to exclude structural pathology. Three previously healthy male patients (aged 25-45) developed acute liver injury during mild febrile illness, all with serologically confirmed SARS-CoV-2 infection (positive IgM and IgG). Retrospective assessment revealed unrecognized metabolic dysfunction-associated steatotic liver disease (MASLD) in all cases. Initial symptoms were fatigue and myalgia without respiratory distress. Laboratory findings demonstrated marked elevations of AST and ALT (>1000 U/L), GGT (>900 U/L), and raised ferritin and D-dimer, while bilirubin remained normal. This biochemical profile - disproportionately elevated transaminases and GGT with preserved bilirubin - was consistent across cases, suggesting SARS-CoV-2-related hepatocellular injury. All patients recovered rapidly with supportive outpatient care, without progression to liver failure.

Conclusion: Clinically stable COVID-19 patients may experience acute hepatocellular injury, particularly those with underlying metabolic dysfunction such as MASLD. The recurring biochemical pattern of significantly elevated AST, ALT, GGT, and ferritin with normal bilirubin suggests a distinctive SARS-CoV-2-associated liver injury phenotype. Recognition of this presentation is essential for appropriate evaluation and management. Routine liver function monitoring should be considered in COVID-19 patients, regardless of respiratory symptom severity, especially in those with metabolic risk factors.

背景:SARS-CoV-2虽然主要是一种呼吸道病原体,但表现出多器官亲和性,肝脏是最常见的感染器官之一。住院的COVID-19患者经常出现肝酶升高,但在年轻、临床稳定的个体中,急性和明显的肝细胞损伤并不常见。潜在的机制可能包括由ACE2受体介导的直接病毒细胞病变效应、免疫介导的损伤、全身炎症和代谢应激。值得注意的是,肝脏受累可独立于呼吸损害而发展。目的:本病例报告的目的是描述3例血清学确诊的SARS-CoV-2感染和轻度呼吸道症状的成人患者,在没有其他可识别原因的情况下表现为急性肝损伤。病例报告:在波斯尼亚和黑塞哥维那确诊的COVID-19浪潮期间,在家庭医学环境中进行了一项有针对性的门诊研究。所有疑似病例均进行肝脏常规检查。实验室评估包括肝酶、肝炎血清学、自身免疫标记物和炎症参数,并使用影像学(超声或MRI)排除结构性病理。3例既往健康男性患者(25-45岁)在轻度发热疾病期间出现急性肝损伤,血清学证实均为SARS-CoV-2感染(IgM和IgG阳性)。回顾性评估显示,所有病例均存在未被识别的代谢功能障碍相关脂肪变性肝病(MASLD)。最初症状为疲劳和肌痛,无呼吸窘迫。实验室结果显示AST和ALT显著升高(1000 U/L), GGT显著升高(900 U/L),铁蛋白和d -二聚体升高,而胆红素保持正常。这种生化特征——转氨酶和GGT不成比例地升高,胆红素保持不变——在所有病例中都是一致的,表明与sars - cov -2相关的肝细胞损伤。所有患者在门诊治疗的支持下迅速恢复,没有进展到肝功能衰竭。结论:临床稳定的COVID-19患者可能出现急性肝细胞损伤,特别是存在潜在代谢功能障碍的患者,如MASLD。反复出现的AST、ALT、GGT和铁蛋白显著升高而胆红素正常的生化模式提示独特的sars - cov -2相关肝损伤表型。认识到这种表现对于适当的评价和管理是必不可少的。COVID-19患者应考虑常规肝功能监测,无论呼吸道症状严重程度如何,特别是有代谢危险因素的患者。
{"title":"Liver Injury During New Epidemic Occurrence of COVID-19.","authors":"Nizama Salihefendic, Muharem Zildzic, Izet Masic","doi":"10.5455/msm.2025.37.261-266","DOIUrl":"10.5455/msm.2025.37.261-266","url":null,"abstract":"<p><strong>Background: </strong>SARS-CoV-2, though primarily a respiratory pathogen, exhibits multi-organ tropism, with the liver among the commonly affected organs. Elevations in liver enzymes are frequent in hospitalized COVID-19 patients, yet acute and pronounced hepatocellular injury in young, clinically stable individuals is uncommon. The underlying mechanisms may include direct viral cytopathic effects mediated by ACE2 receptors, immune-mediated injury, systemic inflammation, and metabolic stress. Notably, hepatic involvement can develop independently of respiratory compromise.</p><p><strong>Objective: </strong>The aim of this case report was to describe three adult patients with serologically confirmed SARS-CoV-2 infection and mild respiratory symptoms who presented with acute liver injury in the absence of other identifiable causes.</p><p><strong>Case report: </strong>During a confirmed COVID-19 wave in Bosnia and Herzegovina, a targeted outpatient study was performed in a family medicine setting. Routine liver testing was conducted for all suspected COVID-19 cases. Laboratory evaluation included liver enzymes, hepatitis serology, autoimmune markers, and inflammatory parameters, with imaging (ultrasound or MRI) to exclude structural pathology. Three previously healthy male patients (aged 25-45) developed acute liver injury during mild febrile illness, all with serologically confirmed SARS-CoV-2 infection (positive IgM and IgG). Retrospective assessment revealed unrecognized metabolic dysfunction-associated steatotic liver disease (MASLD) in all cases. Initial symptoms were fatigue and myalgia without respiratory distress. Laboratory findings demonstrated marked elevations of AST and ALT (>1000 U/L), GGT (>900 U/L), and raised ferritin and D-dimer, while bilirubin remained normal. This biochemical profile - disproportionately elevated transaminases and GGT with preserved bilirubin - was consistent across cases, suggesting SARS-CoV-2-related hepatocellular injury. All patients recovered rapidly with supportive outpatient care, without progression to liver failure.</p><p><strong>Conclusion: </strong>Clinically stable COVID-19 patients may experience acute hepatocellular injury, particularly those with underlying metabolic dysfunction such as MASLD. The recurring biochemical pattern of significantly elevated AST, ALT, GGT, and ferritin with normal bilirubin suggests a distinctive SARS-CoV-2-associated liver injury phenotype. Recognition of this presentation is essential for appropriate evaluation and management. Routine liver function monitoring should be considered in COVID-19 patients, regardless of respiratory symptom severity, especially in those with metabolic risk factors.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 3","pages":"261-266"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infertility - a Great Challenge of the Past, Present, and Future. 不孕不育——过去、现在和未来的巨大挑战。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.74-79
Ivana Erceg Ivkosic, Jana Mesic, Rajko Fures, Zlatko Hrgovic, Luka Bulic, Eva Brenner, Vesna Cosic, Blazenka Miskic, Dinko Kolaric

Background: The Infertility refers to the inability of couples to conceive after 12 months of regular, unprotected sexual intercourse. The incidence of infertility is increasing and is estimated to be 8-12%, or even up to 20%. Primarily, it involves organic causes, but the psychological aspect is not excluded.

Objective: The aim of this article was to discrabe the observing of various causes of infertility.

Methods: Authors used, as sources, published relevant facts in the articles deposited in important scientific indexed databases Medline, Scopus, PubMed Central, Hinari, etc. to write this review.

Results and discussion: The diagnosis of female infertility involves a detailed medical history, laboratory tests, hormonal evaluation, and imaging studies such as ultrasound and eventually hysteroscopy and laparoscopy. Advances in genetic testing have deepened our understanding of infertility origins in both genders. Sperm analysis is pivotal for diagnosing male infertility. Infertility treatment includes identifying causes and applying various therapies, including conservative surgical, and assisted reproductive technology (ART).

Conclusion: The currently used ART methods include ovulation tracking with planned intercourse, insemination and in vitro fertilization (IVF).

背景:不孕症是指夫妇在经过12个月的定期、无保护的性交后仍不能怀孕。不孕症的发病率正在增加,估计为8-12%,甚至高达20%。它主要涉及机体原因,但也不排除心理方面的原因。目的:探讨不孕不育各种病因的观察方法。方法:作者以重要科学索引数据库Medline、Scopus、PubMed Central、Hinari等收录的文章为来源,发表相关事实撰写本综述。结果和讨论:女性不孕症的诊断包括详细的病史、实验室检查、激素评估和影像学检查,如超声和最终的宫腔镜和腹腔镜检查。基因检测的进步加深了我们对男女不孕症起源的理解。精子分析是诊断男性不育症的关键。不孕症的治疗包括确定病因和应用各种疗法,包括保守手术和辅助生殖技术(ART)。结论:目前使用的ART方法包括计划性交、人工授精和体外受精(IVF)。
{"title":"Infertility - a Great Challenge of the Past, Present, and Future.","authors":"Ivana Erceg Ivkosic, Jana Mesic, Rajko Fures, Zlatko Hrgovic, Luka Bulic, Eva Brenner, Vesna Cosic, Blazenka Miskic, Dinko Kolaric","doi":"10.5455/msm.2025.37.74-79","DOIUrl":"10.5455/msm.2025.37.74-79","url":null,"abstract":"<p><strong>Background: </strong>The Infertility refers to the inability of couples to conceive after 12 months of regular, unprotected sexual intercourse. The incidence of infertility is increasing and is estimated to be 8-12%, or even up to 20%. Primarily, it involves organic causes, but the psychological aspect is not excluded.</p><p><strong>Objective: </strong>The aim of this article was to discrabe the observing of various causes of infertility.</p><p><strong>Methods: </strong>Authors used, as sources, published relevant facts in the articles deposited in important scientific indexed databases Medline, Scopus, PubMed Central, Hinari, etc. to write this review.</p><p><strong>Results and discussion: </strong>The diagnosis of female infertility involves a detailed medical history, laboratory tests, hormonal evaluation, and imaging studies such as ultrasound and eventually hysteroscopy and laparoscopy. Advances in genetic testing have deepened our understanding of infertility origins in both genders. Sperm analysis is pivotal for diagnosing male infertility. Infertility treatment includes identifying causes and applying various therapies, including conservative surgical, and assisted reproductive technology (ART).</p><p><strong>Conclusion: </strong>The currently used ART methods include ovulation tracking with planned intercourse, insemination and in vitro fertilization (IVF).</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 1","pages":"74-79"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduction of Serum Interleukin-17 and Interleukin-23 Levels Following Narrow Band Ultraviolet B Treatment in Patients with Moderate-to-severe Psoriasis Vulgaris. 中重度寻常型银屑病患者窄带紫外线B治疗后血清白介素-17和白介素-23水平的降低。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.125-130
Pham Thi Minh Phuong, Tran Thi Huyen, Quach Thi Ha Giang, Trinh Minh Trang, Hoang Thi Phuong, Le Thi Hai Yen, Nguyen Van Thuong, Le Huu Doanh

Background: Psoriasis, a common skin disorder, involves immune cells and cytokines in its pathogenesis. Narrow band ultraviolet B (NB-UVB) treatment has demonstrated efficacy and safety in managing this condition.

Objective: This study aimed to assess changes in serum interleukin (IL)-17, IL-23, and tumor necrosis factor-alpha (TNF-α) levels during NB-UVB treatment for psoriasis vulgaris.

Methods: An interventional, pre-post comparative study was conducted on patients with moderate to severe psoriasis vulgaris undergoing NB-UVB treatment. Patients were randomly allocated to Group 1 (n=39) receiving NB-UVB based on minimal erythema dose (MED) and Group 2 (n=32) based on Fitzpatrick skin type classification. Serum IL-17, IL-23, and TNF-α levels were measured before treatment and upon achieving PASI75.

Results: There were no significant differences in serum IL-17, IL-23, and TNF-α levels between Group 1 and Group 2 at either time point. In Group 1, IL-17 levels decreased from median 2.6 pg/ml before treatment to 2.5 pg/ml at PASI75 (P=0.0107). In Group 2, IL-23 levels decreased from median 9.6 pg/ml pre-treatment to 1.3 pg/ml at PASI75 (P<0.0190). Across all patients, pre-treatment IL-17 and IL-23 levels (median 2.6 pg/ml and 7.1 pg/ml, respectively) were significantly higher compared to levels at PASI75 (P=0.0349 and P=0.0023, respectively).

Conclusion: NB-UVB effectively treats moderate to severe psoriasis vulgaris, leading to reduced serum IL-17 and IL-23 levels irrespective of MED-based or skin type-based dosing strategies.

背景:银屑病是一种常见的皮肤病,其发病涉及免疫细胞和细胞因子。窄带紫外线B (NB-UVB)治疗已被证明是有效和安全的。目的:本研究旨在评估NB-UVB治疗寻常型银屑病期间血清白细胞介素(IL)-17、IL-23和肿瘤坏死因子-α (TNF-α)水平的变化。方法:对中重度寻常型银屑病行NB-UVB治疗的患者进行介入前后对比研究。根据最小红斑剂量(MED)将患者随机分为接受NB-UVB治疗的1组(n=39)和根据Fitzpatrick皮肤类型分型的2组(n=32)。治疗前和达到PASI75后分别测定血清IL-17、IL-23和TNF-α水平。结果:两组患者血清IL-17、IL-23、TNF-α水平差异均无统计学意义。在第1组中,IL-17水平从治疗前的中位数2.6 pg/ml降至PASI75时的2.5 pg/ml (P=0.0107)。在第2组中,IL-23水平从治疗前的中位9.6 pg/ml降至PASI75时的1.3 pg/ml。结论:NB-UVB有效治疗中重度寻常型银屑病,导致血清IL-17和IL-23水平降低,与基于med或基于皮肤类型的给药策略无关。
{"title":"Reduction of Serum Interleukin-17 and Interleukin-23 Levels Following Narrow Band Ultraviolet B Treatment in Patients with Moderate-to-severe Psoriasis Vulgaris.","authors":"Pham Thi Minh Phuong, Tran Thi Huyen, Quach Thi Ha Giang, Trinh Minh Trang, Hoang Thi Phuong, Le Thi Hai Yen, Nguyen Van Thuong, Le Huu Doanh","doi":"10.5455/msm.2025.37.125-130","DOIUrl":"10.5455/msm.2025.37.125-130","url":null,"abstract":"<p><strong>Background: </strong>Psoriasis, a common skin disorder, involves immune cells and cytokines in its pathogenesis. Narrow band ultraviolet B (NB-UVB) treatment has demonstrated efficacy and safety in managing this condition.</p><p><strong>Objective: </strong>This study aimed to assess changes in serum interleukin (IL)-17, IL-23, and tumor necrosis factor-alpha (TNF-α) levels during NB-UVB treatment for psoriasis vulgaris.</p><p><strong>Methods: </strong>An interventional, pre-post comparative study was conducted on patients with moderate to severe psoriasis vulgaris undergoing NB-UVB treatment. Patients were randomly allocated to Group 1 (n=39) receiving NB-UVB based on minimal erythema dose (MED) and Group 2 (n=32) based on Fitzpatrick skin type classification. Serum IL-17, IL-23, and TNF-α levels were measured before treatment and upon achieving PASI75.</p><p><strong>Results: </strong>There were no significant differences in serum IL-17, IL-23, and TNF-α levels between Group 1 and Group 2 at either time point. In Group 1, IL-17 levels decreased from median 2.6 pg/ml before treatment to 2.5 pg/ml at PASI75 (P=0.0107). In Group 2, IL-23 levels decreased from median 9.6 pg/ml pre-treatment to 1.3 pg/ml at PASI75 (P<0.0190). Across all patients, pre-treatment IL-17 and IL-23 levels (median 2.6 pg/ml and 7.1 pg/ml, respectively) were significantly higher compared to levels at PASI75 (P=0.0349 and P=0.0023, respectively).</p><p><strong>Conclusion: </strong>NB-UVB effectively treats moderate to severe psoriasis vulgaris, leading to reduced serum IL-17 and IL-23 levels irrespective of MED-based or skin type-based dosing strategies.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 2","pages":"125-130"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144556317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Materia socio-medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1